Highlights
1 patent
About
Diagnostic Tools for Iron Toxicity in Body Fluids
Aferrix develops tools for the early diagnosis and monitoring of serum iron toxicity. The companys solutions include methods that quantify different forms of toxic iron not detected by conventional tests. Aferrix offers iron testing services and kits for research and treatment centers specializing in iron overload diseases (e.g. thalassemia, hemochromatosis, and myelodysplastic syndrome) and for pharmaceutical companies that are developing iron chelators. All of the companys products are CE marked for IVD use.
Identity
| Name | Aferrix |
|---|---|
| Slug | aferrix |
| Type / kind | startup |
| Crunchbase ID | afferix |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6LoNgJDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Jan 2023 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | South District |
| HQ city | Ashdod |
| HQ address | HaBosem Street 3, Ashdod, Israel |
Web & social
| https://www.linkedin.com/company/18784891 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProvidersLife SciencesPharmaceuticalsBiotechnology
Business models
B2B
Tags
diagnosticspharma-companiesblood-testmeasurementsmedical-technologieslaboratoriesmonitoringdetection
Funding
| Total raised | — |
|---|---|
| Current stage | Mature |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}